The Parkinson’s and Movement Disorder Foundation (PMDF)
is a research-driven nonprofit dedicated to improving the lives of individuals affected by Parkinson’s disease and related movement disorders. By funding innovative research and collaborating with leading clinicians, PMDF works to accelerate the development of effective treatments and bring meaningful advancements into real-world patient care.
What We Do
Research Funding
We support high-impact, clinically relevant research focused on advancing treatment options and improving patient outcomes in Parkinson’s disease and movement disorders.
Clinical Collaboration
We work closely with physicians, researchers, and healthcare institutions to ensure that scientific discoveries translate into practical, real-world care.
Patient Impact
Our initiatives are designed to improve quality of life for patients through better treatment approaches, earlier diagnosis, and more effective disease management.
Education & Awareness
We promote education among clinicians, patients, and the broader community to advance understanding and improve standards of care.
Impact & Results
PMDF is committed to delivering measurable impact through research and collaboration. Our efforts focus on:
-
Supporting innovative clinical research initiatives
-
Advancing new and emerging treatment approaches
-
Improving patient outcomes through clinically driven programs
-
Strengthening the connection between research and real-world care
As we continue to grow, we remain focused on expanding our reach and deepening our impact across the movement disorder community.
Our Approach
What sets PMDF apart is our clinically integrated approach. We prioritize research and initiatives that are directly informed by patient needs and physician experience. By focusing on targeted, high-impact opportunities, we are able to accelerate progress and bring meaningful advancements into practice faster than traditional research pathways.
Partnerships & Collaborations
We collaborate with a network of physicians, research institutions, and healthcare organizations dedicated to advancing neurological care. These partnerships enable us to support innovative research, expand clinical programs, and drive meaningful progress in the treatment of movement disorders.
Transparency & Commitment
PMDF is committed to responsible stewardship of all resources. We prioritize transparency, accountability, and the efficient use of funds to ensure that every contribution supports meaningful research and patient-focused initiatives.
Our Board of Directors
Mark Wadsworth, President
Mark Wadsworth serves as President of the Parkinson’s and Movement Disorder Foundation, providing executive leadership and strategic direction in advancing the Foundation’s mission. In this role, he works closely with the Board of Directors and senior leadership to guide organizational priorities, strengthen partnerships, and support initiatives that accelerate research and improve patient care.
Mr. Wadsworth’s vision is centered on driving sustainable growth, expanding the Foundation’s impact, and fostering collaboration across the clinical and research communities. Through strong governance, strategic leadership, and a commitment to innovation, he is dedicated to advancing progress in the understanding and treatment of Parkinson’s disease and related movement disorders.
Mary-Ann Chapman, Vice President
Mary-ann Chapman serves as Vice President of the Parkinson’s and Movement Disorder Foundation, providing strategic leadership and organizational oversight in support of the Foundation’s mission. She currently serves as Executive Director of the International Association for Parkinson's and Related Disorders, bringing extensive experience in global collaboration, program development, and advancing initiatives within the movement disorder community.
In her role, she works closely with executive leadership and the Board to guide strategic priorities, strengthen partnerships, and support initiatives that advance research and improve patient care.
Ms. Chapman’s vision is centered on fostering sustainable growth, enhancing operational excellence, and expanding the Foundation’s impact. Through collaboration, strategic planning, and a commitment to innovation, she is dedicated to accelerating progress in research and elevating standards of care for patients worldwide.
Gianni Truong, Treasurer
Gianni Truong serves as Treasurer of the Parkinson’s and Movement Disorder Foundation, providing financial oversight and governance in support of the organization’s mission. He is the former Director of the Truong Neuroscience Institute and the Parkinson’s and Movement Disorder Institute, and currently serves as Chief Executive Officer of The Truong Corporation.
In his role as Treasurer, Mr. Truong is responsible for safeguarding the Foundation’s financial integrity, ensuring compliance with applicable standards, and promoting transparency and accountability in all financial matters.
Mr. Truong’s vision is to uphold a disciplined and sustainable financial framework that enables the Foundation to allocate resources efficiently, support high-impact research initiatives, and strengthen long-term institutional growth. Through prudent stewardship and strategic planning, he is committed to ensuring that the Foundation’s assets are managed responsibly to maximize their benefit for patients, clinicians, and the broader movement disorder community.
Sami Nasrawi, Secretary
Sami Nasrawi, PharmD, serves as Secretary of the Parkinson’s and Movement Disorder Foundation, providing governance support and ensuring the integrity of the Foundation’s records, policies, and compliance practices. He currently serves as Director of Medical Outcomes at Alnylam Pharmaceuticals and previously held the role of Senior Clinical Director at OptumInsight.
In his role as Secretary, Dr. Nasrawi is responsible for maintaining accurate organizational documentation, supporting Board operations, and upholding regulatory and governance standards.
Dr. Nasrawi’s vision is centered on strengthening organizational effectiveness through data-driven decision-making, clinical insight, and operational excellence. He is committed to supporting the Foundation’s mission by ensuring strong governance practices that enable sustainable growth and meaningful impact in movement disorder research and patient care.
Get Involved
Join us in advancing the future of neurological care.
-
Support Research – Help fund critical breakthroughs
-
Partner With Us – Collaborate on clinical and research initiatives
-
Stay Connected – Learn more about our work and impact
Together, we can accelerate progress and improve the lives of those affected by Parkinson’s disease and movement disorders.
